ASCO: Favorable Data For J&J Combo in 1L NSCLC Gain Attention

 
• By Jung Won Shin
  
attention
New Standard Of Care For EGFR-mutated NSCLC On Horizon? • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from ASCO

More from Conferences